Skip to main content

Table 2 Reimbursement drug list in Hangzhou and Baoji in 2010

From: Availability, use, and affordability of medicines in urban China under universal health coverage: an empirical study in Hangzhou and Baoji

 

Class Aa

Class Bb

Western medicine

Chinese patent medicine

Reimbursement by insurance

Western medicine

Chinese patent medicine

Reimbursement by insurance

National-level

349

154

100%

791

833

–

Hangzhou

349

154

100%

866

951

80%, 97% and 99% based on drug types

Baoji

349

154

100%

983

961

85%

  1. a Class A drugs are those necessary for clinical use, with good effectiveness and low price. The list of Class A drugs is made by the central government and is identical nationwide
  2. b Class B drugs are those optional for clinical use, with similar effectiveness but higher price compared with Class A drugs. The list of Class B drugs is made by the municipal government